学术探索
学术期刊
新闻热点
数据分析
智能评审

Chemical radioprotection: A critical review of amifostine as a cytoprotector in radiotherapy

被引：158
作者：
Andreassen, CN
Gran, C
Lindegaard, JC
机构：
[1] Aarhus Univ Hosp, Dept Expt Clin Oncol, DK-8000 Aarhus C, Denmark
[2] Aarhus Univ Hosp, Dept Oncol, DK-8000 Aarhus, Denmark
来源：
SEMINARS IN RADIATION ONCOLOGY | 2003年 / 13卷 / 01期
关键词：
D O I：
10.1053/srao.2003.50006
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：62 / 72
页数：11
相关论文
共 95 条
[1]   Altered fractionation trials in head and neck cancer [J].
Ang, KK .
SEMINARS IN RADIATION ONCOLOGY, 1998, 8 (04) :230-236
[2]   A phase II trial of subcutaneous Amifostine and radiation therapy in patients with head and neck cancer [J].
Anné, PR ;
Curran, WJ .
SEMINARS IN RADIATION ONCOLOGY, 2002, 12 (01) :18-19
[3]   Prophylactic use of amifostine to prevent radiochemotherapy-induced mucositis and xerostomia in head-and-neck cancer [J].
Antonadou, D ;
Pepelassi, M ;
Synodinou, M ;
Puglisi, M ;
Throuvalas, N .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 52 (03) :739-747
[4]   Randomized phase III trial of radiation treatment ± amifostine in patients with advanced-stage lung cancer [J].
Antonadou, D ;
Coliarakis, N ;
Synodinou, M ;
Athanassiou, H ;
Kouveli, A ;
Verigos, C ;
Georgakopoulos, G ;
Panoussaki, K ;
Karageorgis, P ;
Throuvalas, N .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2001, 51 (04) :915-922
[5]   Economic analysis of amifostine as adjunctive support for patients with advanced head and neck cancer: Preliminary results from a randomized phase II clinical trial from Germany [J].
Bennett, CL ;
Lane, D ;
Stinson, T ;
Glatzel, M ;
Buntzel, J .
CANCER INVESTIGATION, 2001, 19 (02) :107-113
[6]   CLINICAL-TRIALS OF WR-2721 WITH RADIATION-THERAPY [J].
BLUMBERG, AL ;
NELSON, DF ;
GRAMKOWSKI, M ;
GLOVER, D ;
GLICK, JH ;
YUHAS, JM ;
KLIGERMAN, MM .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1982, 8 (3-4) :561-563
[7]   Radioprotection of salivary glands by S-2-(3-aminopropylamino)-ethylphosphorothioic (amifostine) obtained in a rabbit animal model [J].
Bohuslavizki, KH ;
Klutmann, S ;
Jenicke, L ;
Brenner, W ;
Feyerabend, B ;
Henze, E ;
Clausen, M .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1999, 45 (01) :181-186
[8]   Salivary gland protection by amifostine in high-dose radioiodine treatment: Results of a double-blind placebo-controlled study [J].
Bohuslavizki, KH ;
Klutmann, S ;
Brenner, W ;
Mester, J ;
Henze, E ;
Clausen, M .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (11) :3542-3549
[9]   New dosing regimens for amifostine: A pilot study to compare the relative bioavailability of oral and subcutaneous administration with intravenous infusion [J].
Bonner, HS ;
Shaw, LM .
JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 42 (02) :166-174
[10]   A randomized study of very accelerated radiotherapy with and without amifostine in head and neck squamous cell carcinoma [J].
Bourhis, J ;
De Crevoisier, R ;
Abdulkarim, B ;
Deutsch, E ;
Lusinchi, A ;
Luboinski, B ;
Wibault, P ;
Eschwege, F .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2000, 46 (05) :1105-1108
12345678910